- Home
- Press Release
- Products & Technologies
- Education
- Clinical Studies
Recent News
- 02/26/2013 — Quantason names Dr. Ellen B. Mendelson, Medical Director.
- 02/19/2013 — Quantason has received allowance of Patent 8,376,947.
- 02/12/2013 — Quantason has received allowance of Patent 8,372,006.
- 10/22/2012 — Quantason announces its relocation to Los Angeles, CA.
- 10/22/2012 — Quantason receive $3.2M in Series B investment.
- 10/10/2012 — Peter S. Seidel invests in Quantason, receives Class “A” Units and joins the Board of Directors.
- 06/15/2012 — Michael A. DiGregorio has joined Quantason as a member of the Business Development Team.
- 06/12/2012 — Quantason has received allowance of Patent 8,200,313
- 05/17/2012 — Carolyn F. Bivens invests in Quantason and receives Class “B” Units.
- 3/19/2012 — Carolyn F. Bivens joins Quantason’s Board of Directors
- 02/07/2012 — Quantason has received allowance of Patent 8,109,878 entitled, “Use of coded excitation schemes in the detection and location of a target in a human body such as breast calcifications”.
- 10/25/2011 — Quantason has received allowance of Patent 8,043,217 entitled, “Method and apparatus to quantify specific material properties of objects using real-time ultrasound burst spectrography technique”.
Breast Care Technologies
Explore the latest technologies
in breast care.
Breast Cancer Foundations
